Your browser doesn't support javascript.
loading
Activities of clinical pharmacologists across Europe: A survey by the European association of clinical pharmacology and therapeutics.
Marquet, Pierre; Jouanjus, Emilie; Sáez-Peñataro, Joaquin; Sancho-Lopez, Aranzazu.
Afiliación
  • Marquet P; Department of Pharmacology, Toxicology and Pharmacovigilance, CHU de Limoges, CBRS, 2 rue Bernard Descottes, 87000, Limoges, France. pierre.marquet@unilim.fr.
  • Jouanjus E; Pharmacology & Transplantation, UMR1248 Inserm, Université de Limoges, CHU de Limoges, Limoges, France. pierre.marquet@unilim.fr.
  • Sáez-Peñataro J; Addictovigilance Centre, Department of Medical and Clinical Pharmacology, Toulouse University Hospital, Toulouse, France.
  • Sancho-Lopez A; CERPOP, University of Toulouse, Inserm, Toulouse, France.
Eur J Clin Pharmacol ; 80(6): 919-929, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38466425
ABSTRACT

PURPOSE:

In order to explore clinical pharmacology and therapeutics (CPT) teaching and practices across continental Europe, the European Association of Clinical Pharmacology and Therapeutics (EACPT) made a survey in 2022 amongst its 27 affiliated societies.

METHODS:

The survey was made available online to EACPT representatives, and 47 filled-in questionnaires were received from 25 countries (one to five per country), representing all geographic areas of Europe.

RESULTS:

Clinical pharmacologists (CPs) spend 25%, 30%, 15%, and 25% of their time in teaching, hospital activities, committees, and research, respectively, with large variations across and within countries. CPT courses are given at Schools of Medicine in all the countries except one, mostly organized and taught by medical doctors (MDs). In Central, Western, and Southern Europe, the teachers may have medicine or pharmacy training. Therapeutic drug monitoring and pharmacovigilance were the hospital activities most frequently reported, and clinical/forensic toxicology, rounds of visits, and pharmacogenetics the least. Two-thirds of the panel think CPs should be MDs. However, the transversal nature of CPT was underlined, with patients/diseases and drugs as gravity centres, thus calling for the complementary skills of MDs and PharmDs. Besides, most respondents reported that clinical pharmacists in their country are involved in rounds of visits, pharmacovigilance, TDM, and/or pharmacogenetic testing and that collaborations with them would be beneficial.

CONCLUSION:

CPT comes with a plurality of backgrounds and activities, all required to embrace the different pathologies and the whole lifecycle of medicinal products, but all of them being rarely performed in any given country. The willingness to use common CPT teaching material and prescribing exams at the European level is a good sign of increasing harmonisation of our discipline Europewide.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Farmacología Clínica Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Eur J Clin Pharmacol Año: 2024 Tipo del documento: Article País de afiliación: Francia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Farmacología Clínica Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Eur J Clin Pharmacol Año: 2024 Tipo del documento: Article País de afiliación: Francia
...